1
|
Zhang S, Liao XJ, Wang J, Shen Y, Shi HF, Zou Y, Ma CY, Wang XQ, Wang QG, Wang X, Xu MY, Cheng FF, Bai WZ. Temporal alterations in pericytes at the acute phase of ischemia/reperfusion in the mouse brain. Neural Regen Res 2022; 17:2247-2252. [PMID: 35259845 PMCID: PMC9083170 DOI: 10.4103/1673-5374.336876] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Pericytes, as the mural cells surrounding the microvasculature, play a critical role in the regulation of microcirculation; however, how these cells respond to ischemic stroke remains unclear. To determine the temporal alterations in pericytes after ischemia/reperfusion, we used the 1-hour middle cerebral artery occlusion model, which was examined at 2, 12, and 24 hours after reperfusion. Our results showed that in the reperfused regions, the cerebral blood flow decreased and the infarct volume increased with time. Furthermore, the pericytes in the infarct regions contracted and acted on the vascular endothelial cells within 24 hours after reperfusion. These effects may result in incomplete microcirculation reperfusion and a gradual worsening trend with time in the acute phase. These findings provide strong evidence for explaining the "no-reflow" phenomenon that occurs after recanalization in clinical practice.
Collapse
Affiliation(s)
- Shuang Zhang
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Xue-Jing Liao
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Jia Wang
- Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
| | - Yi Shen
- Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
| | - Han-Fen Shi
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Yan Zou
- Shineway Pharmaceutical Group Ltd., Shijiazhuang, Hebei Province, China
| | - Chong-Yang Ma
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, China
| | - Xue-Qian Wang
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Qing-Guo Wang
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Xu Wang
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Ming-Yang Xu
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Fa-Feng Cheng
- Beijing Key Laboratory, School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Wan-Zhu Bai
- Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
| |
Collapse
|